35 participants
Neoadjuvant Short-Course Radiotherapy Followed by CAPOX Plus PD-1 Antibody and IL-2 in Locally Advanced Rectal Cancer (PRIDE01)
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2026-08-10
- Start Date:
- 2024-10-09
- Completion:
- 2026-06-10
Conditions
- Rectal Cancer
- Advanced Solid Tumor
Interventions
- DRUG
- RADIATION
No Results Yet